The global biomarkers market was valued at US$ 51.2 Billion in 2022 and is projected to expand at a robust CAGR of 10.4% from 2023 to 2031, reaching more than US$ 125.6 Billion by the end of 2031. This strong growth trajectory is driven by the rising prevalence of chronic diseases, increasing adoption of personalized medicine, rapid technological advancements in diagnostics, and expanding...